The polyene macrolide antibiotic amphotericin B (AB) and its chemically modified derivative amphotericin B methyl ester (AME) were tested for in vitro activity against Acholeplasma laidlawii, Spiroplasma citri and Mycoplasma gallisepticum. Both polyene macrolide preparations demonstrated anti-mycoplasmal activity. However, AME was mycoplasmacidal toward all three strains of mycoplasma at levels which previous studies have indicated would be permissible for most cell culture systems, whereas the levels of AB required for similar activity would be physiologically intolerable for tissue culture cells. In addition, AME was 100 fold more active than AB toward A. laidlawii, 10 fold more active than AB toward S. citri and demonstrated equivalent activity as AB toward M. gallisepticum. The in vitro anti-mycoplasmal activity of AME and AB was directly correlated with polyene macrolide antibiotic levels and the number of treated mycoplasma.
657
VOL. XXIX NO. 6 THE JOURNAL OF ANTIBIOTICS
Materials and Methods
Polyene Macrolide Antibiotics: Amphotericin B (AB) was kindly provided by E. R. Squibb and Sons, New Brunswick, N.J. Amphotericin B methyl ester (AME) was synthesized in our laboratory according to procedures previously described.8) Both antibiotics were dissolved in dimethyl sulfoxide (DMSO).
Test Organisms: The three mycoplasmas used in this study were A. laidlawii, S. citri and M.
gallisepticum. A common contaminant of bovine serums and cell culture systems2) is A. laidlawii. A culture of this organism was originally obtained from the American Type Culture Collection, ATCC (#23206). The organism, S. citri, is the causative agent of citrus "Stubborn" disease17,18) which affects orange trees. The microorganism, originally isolated from orange seeds, was obtained from the ATCC (#27556). The fowl mycoplasma, M. gallisepticum, has been isolated from primary chick embryo cell cultures and is a respiratory contaminant in chickens2). This mycoplasmal strain was also obtained from the ATCC (#19610). Growth of Test Organisms: The mycoplasmas, S. citri and A. laidlawii, were grown at 28°C in ATCC plant mycoplasmal medium 675 (ATCC #27563) containing 20% fetal bovine serum (FBS) and 10% yeast extract. The mycoplasma, M. gallisepticum, was grown at 37°C in the same medium.
In Vitro Anti-mycoplasmal Assay: Mycoplasmas in the log phase of growth were pelleted by centrifugation at 12,800 X g for 30 minutes at 4°C. The cells were resuspended in HANKS' balanced salt solution (HBSS), pelleted as above, and 5 ml of HBSS were added to the pellet. Following dilution of each mycoplasmal strain (depending on the initial inoculum), a 1-ml aliquot of diluted cell suspension was pipetted into sterile test tubes and polyene macrolide antibiotics added in varying concentrations. In these studies 5, 10, and 20 pg of AB and 10, 50, and 100 pg of AME were added in 10 pl aliquots of DMSO to the cell suspensions; the final concentration of DMSO was 1 %. The tubes were then incubated for 1 hour at 27°C, and a 0.1-ml aliquot removed and spread on agar prepared with ATCC plant mycoplasma medium #675. Both A. laidlawii and S. citri were incubated at 27°C and M. gallisepticum at 37°C. Colonies were counted under a dissecting microscope.
Results
Amphotericin B (AB) and its chemically modified derivative amphotericin B methyl ester (AME) were both found to be mycoplasmacidal toward A. laidlawii, S. citri and M. gallisepticum (Tables   1~3) . The antimycoplasmal activity exhibited by AB and AME was directly related to the concentration of treated organisms. At the lowest concentration of mycoplasma both AB and AME were very effective in preventing mycoplasmal growth.
Differences in the anti-mycoplasmal activity of AB and AME toward the same test organisms were found. AME was more active than AB in killing A. laidlawii (Table 1 ) and S. cirri (Table 2) . Table  1 .
In both cases, AME was mycoplasmacidal against high concentrations of organisms, even at low drug levels, whereas AB was ineffective in preventing growth at the higher mycoplasma concentrations.
In contrast, AB and AME were similarly mycoplasmacidal toward M. gallisepticum (Table 3 ). The drugs are considered mycoplasmacidal since no growth on agar or in broth tubes was observed following exposure to the drugs.
Variations in the effect of AB and AME toward the three different test organisms were also apparent.
AB and AME were most effective against S. citri. However, AB was least effective against A. laidlawii, whereas AME was least effective against M. gallisepticum.
Discussion
In vitro anti-mycoplasmal activity has been demonstrated with certain polyene macrolide antifungal antibiotics.19~21) In the present study, we evaluated the effect of amphotericin B (AB) and amphotericin B methyl ester (AME) on the in vitro growth of three mycoplasmas: A. laidlawii, S. citri and M. gallisepticum. Although both polyene macrolide preparations were mycoplasmacidal, AME would be a preferable antibiotic for possible use in tissue culture systems because of its reduced toxicity in comparison with AB (Table 4 ). In addition, the most widely used antifungal agent in tissue culture systems, FungizoneR as the deoxycholate complex of AB, has been found to exhibit toxicity13~15, 22) and alter membrane permeability15,22~24) in a number of cell systems. In contrast, AME which demonstrates similar antifungal activity as AB or Fungizone9~11)is not as deleterious to cell culture systems and can be used at higher levels than either AB or Fungizone (Table 4 ).12~15)
Mode of action studies implicate the cell membrane sterols as the site of polyene macrolide antibiotic action .19,21,25,26)Polyene macrolide-membrane interactions can result in permeability alterations and a leakage of essential metabolites from cells resulting in death. 15, 21) The differential effect of AB and AME toward the three strains of mycoplasma studied may result from differences in the amount, type and/or molecular orientation of specific sterol(s) in the membranes of these organisms.
The mycoplasmacidal activity of both AB and AME was directly related to the mycoplasmal inoculum size. This concentration-dependent phenomenon may result from competitive binding be-VOL. XXIX NO. 6 THE JOURNAL OF ANTIBIOTICS Table 4 . Comparative toxicity of amphotericin B (AB) and amphotericin B methyl ester (AME) toward different cell lines 
(13) tween the specific polyene macrolide and the mycoplasmal membrane. A specific number of polyene macrolide molecules per cell may be necessary to induce toxicity. When an excess of organisms are used insufficient levels of polyene macrolide may bind to each cell and consequently not kill the organism.
In comparing the mycoplasmacidal activity of AME and AB, differences in the activity of these antibiotics toward A. laidlawii (Table 1 ) and S. citri (Table 2) were noted. AME was more mycoplasmacidal than AB toward both organisms. This difference in activity may be related to the different physico-chemical properties of AME and AB.8)AME is water soluble and approaches molecular dispersion in aqueous solutions, whereas AB is highly water insoluble and forms large micelles in aqueous solution.8)As compared to AB higher levels of AME may therefore be available in solution to bind to the mycoplasmal membrane and kill these organisms. It is also possible that the membrane damage caused by AME is more extensive. The differences in the structure of the membranes of A. laidlawii and S. citri may also affect the binding and toxic properties of AME and AB. We are presently investigating the mechanism involved in the differential toxicity of AME and AB toward the same and different mycoplasmas and the applicability of AME as an anti-mycoplasmal agent for use in various tissue culture systems.
